ezlopitant has been researched along with venlafaxine in 1 studies
Studies (ezlopitant) | Trials (ezlopitant) | Recent Studies (post-2010) (ezlopitant) | Studies (venlafaxine) | Trials (venlafaxine) | Recent Studies (post-2010) (venlafaxine) |
---|---|---|---|---|---|
22 | 2 | 1 | 69 | 0 | 36 |
Protein | Taxonomy | ezlopitant (IC50) | venlafaxine (IC50) |
---|---|---|---|
Aldo-keto reductase family 1 member B1 | Rattus norvegicus (Norway rat) | 2.708 | |
Sodium-dependent noradrenaline transporter | Homo sapiens (human) | 2.1114 | |
Sodium-dependent serotonin transporter | Homo sapiens (human) | 0.0625 | |
Sodium-dependent serotonin transporter | Rattus norvegicus (Norway rat) | 0.3955 | |
Sodium-dependent dopamine transporter | Homo sapiens (human) | 6.33 | |
Transporter | Rattus norvegicus (Norway rat) | 0.64 | |
Beta-2 adrenergic receptor | Cavia porcellus (domestic guinea pig) | 0.027 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolivette, LJ; Nagilla, R; Ward, KW | 1 |
1 other study(ies) available for ezlopitant and venlafaxine
Article | Year |
---|---|
Comparative evaluation of oral systemic exposure of 56 xenobiotics in rat, dog, monkey and human.
Topics: Administration, Oral; Animals; Area Under Curve; Dogs; Haplorhini; Humans; Models, Statistical; Rats; Software; Species Specificity; Xenobiotics | 2005 |